Suchergebnisse - "Yang, Jianliang"

PubPharm (133)

1

Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma : Insights into Treatment Outcomes

enthalten in: Targeted oncology | 2024

von Xie, Z. | Qin, Y. | Chen, X. | +9

2

High-Throughput Antigen Microarray Identifies Longitudinal Prognostic Autoantibody for Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer

enthalten in: Molecular & cellular proteomics : MCP | 2024

von Dai, L. | Tan, Q. | Li, L. | +13

3

Genetic landscape and prognostic value of IRF4 alterations in Diffuse large B-cell lymphoma patients

enthalten in: ResearchSquare.com | 2024

von Qin, Y. | Chen, X. | Xie, Z. | +9

4

Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Tan, Q. | Gao, R. | Zhang, X. | +12

5

Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients

enthalten in: Cancer immunology immunotherapy | 2024

von Tan, Q. | Gao, R. | Zhang, X. | +12

6

Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era : a multi-institutional cohort study

enthalten in: Annals of hematology | 2024

von Zhong, Q. | Chen, H. | Chen, D. | +11

7

Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study

enthalten in: Annals of hematology | 2023

von Zhong, Q. | Chen, H. | Chen, D. | +11

8

The clinical features, treatment, and prognostic factors for peripheral T-cell lymphomas : A single-institution analysis of 240 Chinese patients

enthalten in: Asia-Pacific journal of clinical oncology | 2023

von Chen, H. | Tao, Y. | Zhou, Y. | +10

9

MYD88L265P and MYD88other variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma

enthalten in: Journal of cancer research and clinical oncology | 2023

von Qin, Y. | Qiu, T. | Xie, Z. | +11

10

Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients

enthalten in: European journal of haematology | 2023

von Qin, Y. | He, X. | Chen, X. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]